| Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study MLK Han, Y Zhou, S Murray, N Tayob, I Noth, VN Lama, BB Moore, ... The Lancet Respiratory Medicine 2 (7), 548-556, 2014 | 379 | 2014 |
| T2–FLAIR mismatch, an imaging biomarker for IDH and 1p/19q status in lower-grade gliomas: a TCGA/TCIA project SH Patel, LM Poisson, DJ Brat, Y Zhou, L Cooper, M Snuderl, C Thomas, ... Clinical cancer research 23 (20), 6078-6085, 2017 | 322 | 2017 |
| Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment M Lu, Y Zhou, IV Haller, RJ Romanelli, JJ VanWormer, CV Rodriguez, ... Clinical Gastroenterology and Hepatology 16 (8), 1342-1350. e1, 2018 | 104 | 2018 |
| Idiopathic pulmonary fibrosis: gender-age-physiology index stage for predicting future lung function decline ML Salisbury, M Xia, Y Zhou, S Murray, N Tayob, KK Brown, AU Wells, ... Chest 149 (2), 491-498, 2016 | 93 | 2016 |
| Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis BB Moore, C Fry, Y Zhou, S Murray, MLK Han, FJ Martinez, KR Flaherty, ... Frontiers in Medicine 1, 56, 2014 | 70 | 2014 |
| Factors associated with prevalence and treatment of primary biliary cholangitis in United States health systems M Lu, J Li, IV Haller, RJ Romanelli, JJ VanWormer, CV Rodriguez, ... Clinical Gastroenterology and Hepatology 16 (8), 1333-1341. e6, 2018 | 69 | 2018 |
| Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes J Li, SC Gordon, LB Rupp, T Zhang, S Trudeau, SD Holmberg, ... Alimentary pharmacology & therapeutics 49 (5), 599-608, 2019 | 51 | 2019 |
| Infrequent clinical assessment of chronic hepatitis B patients in United States general healthcare settings PR Spradling, J Xing, LB Rupp, AC Moorman, SC Gordon, ET Teshale, ... Clinical Infectious Diseases 63 (9), 1205-1208, 2016 | 49 | 2016 |
| Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States J Li, T Zhang, SC Gordon, LB Rupp, S Trudeau, SD Holmberg, ... Journal of viral hepatitis 25 (8), 952-958, 2018 | 38 | 2018 |
| Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006–2013 PR Spradling, J Xing, LB Rupp, AC Moorman, SC Gordon, ET Teshale, ... Alimentary pharmacology & therapeutics 44 (10), 1080-1089, 2016 | 37 | 2016 |
| Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma M Lu, J Li, LB Rupp, SD Holmberg, AC Moorman, PR Spradling, ... Journal of viral hepatitis 23 (9), 718-729, 2016 | 35 | 2016 |
| Race, age, and geography impact hepatitis C genotype distribution in the United States SC Gordon, S Trudeau, J Li, Y Zhou, LB Rupp, SD Holmberg, ... Journal of clinical gastroenterology 53 (1), 40-50, 2019 | 29 | 2019 |
| Alcohol‐related hepatitis admissions increased 50% in the first months of the COVID‐19 pandemic in the USA HC Gonzalez, Y Zhou, FM Nimri, LB Rupp, S Trudeau, SC Gordon Liver International 42 (4), 762-764, 2022 | 27 | 2022 |
| Sustained virological response does not improve long‐term glycaemic control in patients with type 2 diabetes and chronic hepatitis C J Li, SC Gordon, LB Rupp, T Zhang, S Trudeau, SD Holmberg, ... Liver international 39 (6), 1027-1032, 2019 | 26 | 2019 |
| Comparison of ICD-9 codes for depression and alcohol misuse to survey instruments suggests these codes should be used with caution JA Boscarino, AC Moorman, LB Rupp, Y Zhou, M Lu, EH Teshale, ... Digestive diseases and sciences 62, 2704-2712, 2017 | 23 | 2017 |
| Higher all‐cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CH e CS), 2006–2013 EH Teshale, J Xing, A Moorman, SD Holmberg, PR Spradling, SC Gordon, ... Journal of viral hepatitis 23 (10), 748-754, 2016 | 22 | 2016 |
| Changing trends in complications of chronic hepatitis C M Lu, J Li, LB Rupp, Y Zhou, SD Holmberg, AC Moorman, PR Spradling, ... Liver International 38 (2), 239-247, 2018 | 18 | 2018 |
| Effect of treatment of hepatitis B patients with tenofovir disoproxil or entecavir on risk of hepatocellular cancer death in a US Cohort SC Gordon, Y Zhou, J Li, LB Rupp, JA Boscarino, YG Daida, MA Schmidt, ... J Hepatol 70 (1 Suppl), e147, 2019 | 17 | 2019 |
| Investigators C. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study MK Han, Y Zhou, S Murray, N Tayob, I Noth, VN Lama, BB Moore, ... Lancet Respir Med 2, 548-556, 2014 | 17 | 2014 |
| Psychosocial obstacles to hepatitis C treatment initiation among patients in care: a hitch in the cascade of cure PR Spradling, Y Zhong, AC Moorman, LB Rupp, M Lu, SC Gordon, ... Hepatology Communications 5 (3), 400-411, 2021 | 16 | 2021 |
